These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 15255802)

  • 41. Biotransformation of chlorzoxazone by hepatic microsomes from humans and ten other mammalian species.
    Court MH; Von Moltke LL; Shader RI; Greenblatt DJ
    Biopharm Drug Dispos; 1997 Apr; 18(3):213-26. PubMed ID: 9113344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cytochrome P450 2E1 activity in diabetic and obese patients as assessed by chlorzoxazone hydroxylation.
    Lucas D; Farez C; Bardou LG; Vaisse J; Attali JR; Valensi P
    Fundam Clin Pharmacol; 1998; 12(5):553-8. PubMed ID: 9794154
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of endotoxin administration on the pharmacokinetics of chlorzoxazone in humans.
    Poloyac SM; Tosheva RT; Gardner BM; Shedlofsky SI; Blouin RA
    Clin Pharmacol Ther; 1999 Dec; 66(6):554-62. PubMed ID: 10613610
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression and activity of the cytochrome P450 2E1 in patients with nonalcoholic steatosis and steatohepatitis.
    Chtioui H; Semela D; Ledermann M; Zimmermann A; Dufour JF
    Liver Int; 2007 Aug; 27(6):764-71. PubMed ID: 17617119
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of steady-state lasofoxifene on CYP2D6- and CYP2E1-mediated metabolism.
    Moller RA; Fisher JM; Taylor AE; Kolluri S; Gardner MJ; Obach RS; Walsky RL
    Ann Pharmacother; 2006 Jan; 40(1):32-7. PubMed ID: 16368922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of diosmin pretreatment on the pharmacokinetics of chlorzoxazone in healthy male volunteers.
    Rajnarayana K; Venkatesham A; Nagulu M; Srinivas M; Krishna DR
    Drug Metabol Drug Interact; 2008; 23(3-4):311-21. PubMed ID: 19326774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phenobarbital induces monkey brain CYP2E1 protein but not hepatic CYP2E1, in vitro or in vivo chlorzoxazone metabolism.
    Lee AM; Joshi M; Yue J; Tyndale RF
    Eur J Pharmacol; 2006 Dec; 552(1-3):151-8. PubMed ID: 17049344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modulation of CYP2E1 activity by isoniazid in rapid and slow N-acetylators.
    O'Shea D; Kim RB; Wilkinson GR
    Br J Clin Pharmacol; 1997 Jan; 43(1):99-103. PubMed ID: 9056059
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cytochrome P450 2E1 genotype and the susceptibility to antituberculosis drug-induced hepatitis.
    Huang YS; Chern HD; Su WJ; Wu JC; Chang SC; Chiang CH; Chang FY; Lee SD
    Hepatology; 2003 Apr; 37(4):924-30. PubMed ID: 12668988
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhibition of chlorzoxazone metabolism, a clinical probe for CYP2E1, by a single ingestion of watercress.
    Leclercq I; Desager JP; Horsmans Y
    Clin Pharmacol Ther; 1998 Aug; 64(2):144-9. PubMed ID: 9728894
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabolic oxidation and toxification of N-methylformamide catalyzed by the cytochrome P450 isoenzyme CYP2E1.
    Hyland R; Gescher A; Thummel K; Schiller C; Jheeta P; Mynett K; Smith AW; Mráz J
    Mol Pharmacol; 1992 Feb; 41(2):259-66. PubMed ID: 1538706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial dysfunction by gamma-irradiation accompanies the induction of cytochrome P450 2E1 (CYP2E1) in rat liver.
    Chung HC; Kim SH; Lee MG; Cho CK; Kim TH; Lee DH; Kim SG
    Toxicology; 2001 Mar; 161(1-2):79-91. PubMed ID: 11295257
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatic disposition of the cytochrome P450 2E1 marker chlorzoxazone and its hydroxylated metabolite in isolated perfused rat livers.
    Mehvar R; Vuppugalla R
    J Pharm Sci; 2006 Jul; 95(7):1414-24. PubMed ID: 16724323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatic cytochrome P450 2E1 activity in nonalcoholic fatty liver disease.
    Prompila N; Wittayalertpanya S; Komolmit P
    J Med Assoc Thai; 2008 May; 91(5):733-8. PubMed ID: 18672640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cytochrome P4502E1 inducibility and hydroxyethyl radical formation among alcoholics.
    Dupont I; Lucas D; Clot P; Ménez C; Albano E
    J Hepatol; 1998 Apr; 28(4):564-71. PubMed ID: 9566824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chlorzoxazone as a single sample probe of hepatic CYP2E1 activity in humans.
    Bachmann K; Sarver JG
    Pharmacology; 1996 Mar; 52(3):169-77. PubMed ID: 8849486
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chlorzoxazone, a selective probe for phenotyping CYP2E1 in humans.
    Lucas D; Ferrara R; Gonzalez E; Bodenez P; Albores A; Manno M; Berthou F
    Pharmacogenetics; 1999 Jun; 9(3):377-88. PubMed ID: 10471070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chlorzoxazone metabolism by porcine cytochrome P450 enzymes and the effect of cytochrome b5.
    Wiercinska P; Squires EJ
    Drug Metab Dispos; 2010 May; 38(5):857-62. PubMed ID: 20164110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression, catalytic activity, and inducibility of cytochrome P450 2E1 (CYP2E1) in the rat central nervous system.
    Tindberg N; Ingelman-Sundberg M
    J Neurochem; 1996 Nov; 67(5):2066-73. PubMed ID: 8863515
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pharmacokinetics of intravenous chlorzoxazone in rats with dehydration and rehydration: effects of food intakes.
    Kim YC; Kim YG; Kim EJ; Cho MK; Kim SG; Lee MG
    Biopharm Drug Dispos; 2003 Mar; 24(2):53-61. PubMed ID: 12619050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.